⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
KPRX News
Kiora Pharmaceuticals, Inc. Common Stock
Form 8-K
sec.gov
KPHMW
KPRX
Kiora Pharmaceuticals Appoints Keith J. Lane as Executive Vice President of Global Clinical Development and Regulatory Affairs Ready to Announce with Confidence?
newsfilecorp.com
KPRX
Kiora Pharmaceuticals Licenses South Korean Ophthalmic Development and Commercialization Rights for KIO-301 to Chong Kun Dang Pharmaceutical Corporation Ready to Announce with Confidence?
newsfilecorp.com
KPRX
Form 8-K
sec.gov
KPHMW
KPRX
Form 8-K
sec.gov
KPRX
KPHMW
Form 8-K
sec.gov
SSII
RBOT
KPRX
Kiora Pharmaceuticals to Participate in Piper Sandler Virtual Ophthalmology Symposium Ready to Announce with Confidence?
newsfilecorp.com
KPRX
Kiora Pharmaceuticals Reports its Ion Channel Modulator, KIO-300, Suppressed Seizure Activity in Preclinical Epilepsy Model Ready to Announce with Confidence?
newsfilecorp.com
KPRX
Form 8-K
sec.gov
KPHMW
KPRX
Form 8-K
sec.gov
KPHMW
KPRX